 WES MOORE, Governor  Ch. 729  
 
– 1 – Chapter 729  
(House Bill 1243 ) 
 
AN ACT concerning  
 
Health Insurance – Coverage for Specialty Drugs  
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 
maintenance organizations from excluding coverage for certain specialty drugs that 
are administered or dispensed by a provider that meets certain criteria; requiring 
the reimbursement rate for certain specialty drugs to meet certain crite ria; and 
generally relating to health insurance coverage for specialty drugs.  
 
BY repealing and reenacting, without amendments,  
 Article – Insurance  
Section 15 –847(a)(1) and (5)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Insurance  
Section 15 –847(d), 15 –1611.1, and 15 –1612  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
BY adding to  
 Article – Insurance  
Section 15–847(h) and  15–847.2  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2024 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Insurance  
 
15–847. 
 
 (a) (1) In this section the following words  have the meanings indicated.  
 
  (5) (i) “Specialty drug” means a prescription drug that:  
 
    1. is prescribed for an individual with a complex or chronic 
medical condition or a rare medical condition;  
 
    2. costs $600 or more for up to a 30 –day supply;  
Ch. 729  2025 LAWS OF MARYLAND   
 
– 2 –  
    3. is not typically stocked at retail pharmacies; and  
 
    4. A. requires a difficult or unusual process of delivery to 
the patient in the preparation, handling, storage, inventory, or distribution of the drug; or  
 
    B. requires enhanced patient ed ucation, management, or 
support, beyond those required for traditional dispensing, before or after administration of 
the drug.  
 
   (ii) “Specialty drug” does not include a prescription drug prescribed 
to treat diabetes, HIV, or AIDS.  
 
 (d) Subject to SUBSE CTION (H) OF THIS SECTION AND  § 15–805 of this subtitle 
[and], notwithstanding § 15 –806 of this subtitle, [nothing in ] AND EXCEPT AS PROVID ED 
IN § 15–847.2  OF THIS SUBTITLE , this article or regulations adopted under this article 
[precludes ] DO NOT PRECLUDE  an entity subject to this section from requiring a covered 
specialty drug to be obtained through:  
 
  (1) a designated pharmacy or other source authorized under the Health 
Occupations Article to dispense or administer prescription drugs; or  
 
  (2) a pharma cy participating in the entity’s provider network, if the entity 
determines that the pharmacy:  
 
   (i) meets the entity’s performance standards; and  
 
   (ii) accepts the entity’s network reimbursement rates.  
 
 (H) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 
SPECIALTY DRUGS ADMI NISTERED TO PATIENTS  IN A SETTING REGULAT ED BY THE 
HEALTH SERVICES COST REVIEW COMMISSION .  
 
15–847.2.  
 
 (A) IN THIS SECTION , “SPECIALTY DRUG ” HAS THE MEANING STATED IN § 
15–847 OF THIS SUBTITLE . 
 
 (B) (1) THIS SECTION APPLIES TO: 
 
   (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 
PROVIDE COVERAGE FOR  PRESCRIPTION DRUGS U NDER INDIVIDUAL , GROUP , OR 
BLANKET HEALTH INSUR ANCE POLICIES OR CON TRACTS THAT  ARE ISSUED OR 
DELIVERED IN THE STATE ; AND 
 WES MOORE, Governor  Ch. 729  
 
– 3 –  
   (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 
COVERAGE FOR PRESCRI PTION DRUGS UNDER IN DIVIDUAL OR GROUP CO NTRACTS 
THAT ARE ISSUED OR D ELIVERED IN THE STATE . 
 
  (2) AN INSURER , A NONPROFIT HEALTH S ERVICE P LAN, OR A HEALTH 
MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 
DRUGS THROUGH A PHAR MACY BENEFITS MANAGE R IS SUBJECT TO THE 
REQUIREMENTS OF THIS  SECTION . 
 
 (C) AN ENTITY SUBJECT TO THIS SECTION MAY NOT  EXCLUDE COVERAGE 
FOR A COVERED SPECI ALTY DRUG ADMINISTER ED OR DISPENSED BY A  PROVIDER 
UNDER § 12–102 OF THE HEALTH OCCUPATIONS ARTICLE IF THE ENTITY  
DETERMINES THAT : 
 
  (1) THE PROVIDER THAT AD MINISTERS OR DISPENS ES THE COVERED 
SPECIALTY DRUG : 
 
   (I) IS AN IN –NETWORK PROVIDER OF COVERED MED ICAL  
ONCOLOGY SERVICES ; AND  
 
   (II) COMPLIES WITH STATE REGULATIONS FOR  THE 
ADMINISTERING AND DI SPENSING OF SPECIALT Y DRUGS ; AND 
 
  (2) THE COVERED SPECIALT Y DRUG IS : 
 
   (I) INFUSED , AUTO–INJECTED , OR AN ORAL TARGETED 
IMMUNE MODULATOR ; OR 
 
   (II) AN ORAL MEDICATION THAT : 
 
    1. REQUIRES COMPLEX DOS ING BASED ON CLINICA L 
PRESENTATION ; OR 
 
    2. IS USED CONCOMITANTL Y WITH OTHER INFUSIO N OR 
RADIATION THERAPIES . 
 
 (D) (1) THE SUBJECT TO SUBSECTION  (F) OF THIS SECTION , THE 
REIMBURSEMENT RATE F OR SPECIALTY  DRUGS COVERED UNDER THIS SECTION 
SHALL BE : 
 
  (1) (I) AGREED TO BY THE COV ERED , IN–NETWORK PROVIDER AND  
THE ENTITY SUBJECT T O THIS SECTION ; AND  
 
Ch. 729  2025 LAWS OF MARYLAND   
 
– 4 –   (2) (II) BILLED AT A NONHOSPI TAL LEVEL OF CARE OR  PLACE OF 
SERVICE . 
 
  (2) UNLESS OTHERWISE AGRE ED TO BY THE  COVERED , IN–NETWORK 
PROVIDER AND THE ENT ITY SUBJECT TO THIS SECTION , THE REIMBURSEMENT RA TE 
FOR SPECIALTY DRUGS COVERED UNDER THIS S ECTION MAY NOT EXCEE D THE RATE 
APPLICABLE TO A DESI GNATED SPECIALTY PHA RMACY FOR DISPENSING  THE 
COVERED SPECIALTY DR UGS.  
 
 (E) THIS SECTION DOES NOT  PROHIBIT AN ENTITY S UBJECT TO THIS 
SECTION FROM REFUSIN G TO AUTHORIZE OR AP PROVE OR FROM DENYIN G 
COVERAGE FOR A COVER ED SPECIALTY DRUG AD MINISTERED OR DISPEN SED BY A 
PROVIDER IF ADMINIST ERING OR DISPENSING THE DRUG FAILS TO SA TISFY 
MEDICAL NECESSITY CR ITERIA . 
 
 (F) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 
SPECIALTY DRUGS ADMI NISTERED TO PATIENTS  IN A SETTING REGULAT ED BY THE 
HEALTH SERVICES COST REVIEW COMMISSION .  
 
15–1611.1.  
 
 (a) This section applies only to a pharmacy benefits manager that provides 
pharmacy benefits management services on behalf of a carrier.  
 
 (b) Except as provided in subsection (c) of this section, a pharmacy benefits 
manager may not require that a beneficiary use a specific pharmacy or entity to fill a 
prescription if:  
 
  (1) the pharmacy benefits manager or a corporate affiliate of the pharmacy 
benefits manager has an ownership interest in the pharmacy or entity; or  
 
  (2) the pharmacy or entity has an ownership interest in the pharmacy 
benefits manager or a corporate affiliate of the pharmacy benefits manager.  
 
 (c) [A] EXCEPT AS PROVIDED IN  § 15–847.2  OF THIS TITLE , A pharmacy 
benefits manager may require a beneficiary to us e a specific pharmacy or entity for a 
specialty drug as defined in § 15 –847 of this title.  
 
15–1612.  
 
 (a) This section applies only to a pharmacy benefits manager that provides 
pharmacy benefits management services on behalf of a carrier.  
 
 (b) This section does not apply to reimbursement:  
 WES MOORE, Governor  Ch. 729  
 
– 5 –  
  (1) EXCEPT AS PROVIDED I N § 15–847.2  OF THIS TITLE , for specialty 
drugs;  
 
  (2) for mail order drugs; or  
 
  (3) to a chain pharmacy with more than 15 stores or a pharmacist who is 
an employee of the chain pharmac y. 
 
 (c) A pharmacy benefits manager may not reimburse a pharmacy or pharmacist 
for a pharmaceutical product or pharmacist service in an amount less than the amount that 
the pharmacy benefits manager reimburses itself or an affiliate for providing the same  
product or service.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 
after January 1, 2026.  
 
 SECTION 3. AND BE IT FURTHER ENACTED, That  this Act shall take effect 
January 1, 2026.  
 
Approved by the Governor, May 20, 2025.  